daratumumab plus vmp for ndmm: alcyone follow-up
Published 4 years ago • 89 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
5:28
breaking news from the alcyone study of vmp plus daratumumab for ndmm
-
4:03
maia and alcyone: follow-up of daratumumab in multiple myeloma
-
5:07
daratumumab in the management of al amyloidosis
-
2:43
impact of the addition of daratumumab to the frontline treatment of patients with al amyloidosis
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
2:42
final results of the dart4mm study of daratumumab for mrd eradication in myeloma
-
2:42
promising results for daratumumab in the front line setting
-
3:36
daratumumab practical considerations in mm
-
55:28
daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone...
-
13:43
darzalex® iv (daratumumab) mechanism of action for multiple myeloma
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
1:09
daratumumab enhancement for mm: the clinical impact
-
2:39
subcutaneous daratumumab: an update on the latest mm clinical trials
-
2:30
daratumumab and isatuximab in the treatment of multiple myeloma
-
9:41
the i4mds consortium and immune monitoring in mds
-
2:41
optimizing the use of daratumumab in al amyloidosis
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:21
daratumumab with atra in r/r mm
-
1:34
personalizing treatment of transfusion-dependent anemia in lr-mds
-
3:05
sc daratumumab plus standard-of-care regimens in myeloma
-
1:51
darazadex: a phase ii trial of daratumumab plus azacitidine and dexamethasone in r/r myeloma